Lv7
4610 积分 2021-06-08 加入
In vivo generation of anti-BCMA CAR-T cells in relapsed or refractory multiple myeloma: a phase 1 study
5天前
已完结
Clinical Pharmacology and Translational Considerations in the Development of CRISPR‐Based Therapies
7天前
已完结
Lentiviral In Vivo CD19 CAR T-Cell Therapy in Neurologic Autoimmune Disorders
1个月前
已完结
Single-cell profiling of immune reset in patients with refractory generalized myasthenia gravis receiving autologous CD19/BCMA CAR-T cell therapy
2个月前
已完结
Co-infusion of CD19-targeting and BCMA-targeting CAR-T cells for treatment-refractory systemic lupus erythematosus: a phase 1 trial
2个月前
已完结
An iPSC-derived CD19/BCMA CAR-NK therapy in a patient with systemic sclerosis
2个月前
已完结
Validation of BCMA-CD19 Compound CAR-T Therapy in SLE Overlap Syndrome: Over 1.5-Year Follow-Up
2个月前
已完结
BCMA-CD19 compound CAR T cells for systemic lupus erythematosus: a phase 1 open-label clinical trial
2个月前
已完结
The Evolving Landscape of CAR T-Cell Therapy in Autoimmune Diseases: A State-of-the-Art Review (2025)
2个月前
已完结
CM313, a Novel Anti-CD38 Antibody, As a Potential Treatment for Primary Immune Thrombocytopenia: A Phase II Trial
2个月前
已关闭
皖公网安备34019202002308
